20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION
#3002Treatment of neurological disorders
#3003SYNTHETIC BILE ACID COMPOSITIONS AND METHODS
#3004In-Situ Crosslinkable Elastin-Like Polypeptides for Defect Filling in Cartilaginous Tissue Repair
#3005Immunoregulatory compositions
#3006Viral/bacterial toxin polypeptides and methods of using same
#3007Peptides, derivatives and analogs thereof, and methods of using same
#3008Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue
#3009Methods and compositions for the inhibition of thrombus formation
#3010HLA class I A2 tumor associated antigen peptides and vaccine compositions
#3011Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
#3012Pharmaceutical compositions including low dosages of desmopressin
#3013Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
#3014Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
#3015Protein kinase C peptides for use in withdrawal
#3016TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING
#3017METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS
#3018Endoparasiticidal Compositions
#3019Use of native peptides and their optimized derivatives for vaccination
#3020Induction of differential stress resistance and uses thereof
#3021Stratification
#3022Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds
#3023Indibulin therapy
#3024COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUE AND CELLS FROM IMMUNE SYSTEM-MEDIATED DAMAGE
#3025Antimicrobial Peptides
#3026METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS USING ANTAGONISTS
#3027Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
#3028Peptides for preventing or treating liver damage
#3029Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization
#3030Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
#3031Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1
#3032Kinin Antagonists For Treating Bladder Dysfunction
#3033METHODS FOR PRODUCTION OF THE OXIDIZED GLUTATHIONE COMPOSITE WITH CIS-DIAMMINEDICHLOROPLATINUM AND PHARMACEUTICAL COMPOSITIONS BASED THEREOF REGULATING METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOTIC MECHANISMS FOR NORMAL AND TRANSFORMED CELLS
#3034Lkktet and/or Lkktnt Peptide Compositions and Methods
#3035Compositions for Targeting Amine Oxidases in Vivo
#3036Synthetic peptides and methods of use for autoimmune disease therapies
#3037IAP BIR domain binding compounds
#3038MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES
#3039Amphipathic glycopeptides
#3040Dermatological compositions including oligopeptides for increasing skin sensitivity and neuronal perception
#3041Sustained release polymer
#3042AT4 RECEPTOR LIGANDS AS ANGIOGENIC, ANTI-ANGIOGENIC, AND ANTI-TUMOR AGENTS
#3043Treatment of iatrogenic disease
#3044CANCER TREATMENT METHODS USING CADHERIN ANTAGONISTS IN COMBINATION WITH ANTICANCER AGENTS
#3045METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS
#3046NY-ESO-1 peptides which bind to class II molecules and uses thereof
#3047Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#3048Somatostatin antagonists
#3049Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
#3050Method for induction and enhancement of apoptosis in tumor cells
#3051Protective factors against inflammation, burns and noxious stimuli
#3052Pain-sensitive therapeutic wound dressing
#3053Skin rejuvenation cream
#3054Treatment of tumors
#3055INHIBITORS OF GLYCOSAMINOGLYCANS
#3056Bladder tumor-targeting peptide and use thereof
#3057Methods of Treatment For Injured or Diseased Joints
#3058Remedies for sex hormone dependent disease
#3059Therapeutic administration of the scrambled anti-angiogenic peptide C16Y
#3060Cardiovascular compositions and methods using combinations of anti-platelet agents
#3061METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS USING PEPTIDES
#3062Materials and methods for the treatment of celiac disease
#3063Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation
#3064Peptide sustained release compositions and uses thereof
#3065Composition and methods for promoting wound healing and tissue regeneration
#3066OPHTHALMIC COMPOSITIONS COMPRISING DIGLYCINE
#3067Personal care compositions
#3068Compositions and Methods for Inhibiting Cellular Proliferation
#3069IMMUNOREGULATORY COMPOSITIONS
#3070Pharmaceutical formulation
#3071IAP BIR domain binding compounds
#3072MIXTURE FOR TRANSDERMAL DELIVERY OF LOW AND HIGH MOLECULAR WEIGHT COMPOUNDS
#3073Fibrinogen Targetting Microparticles For Promoting Haemostasis
#3074Amino-acid containing composition for inhibiting accumulation of fat
#3075Combination therapy for the treatment of Alzheimer's disease
#3076Hemiasterlin derivatives and uses thereof in the treatment of cancer
#3077Compounds and methods for modulating cell-adhesion mediated drug resistance
#3078N-terminally modified GLP-1 receptor modulators
#3079Skin care compositions containing silicone elastomers
#3080METHODS FOR TREATING SEPTIC SHOCK
#3081Medical device coated with a coating containing elastin pentapeptide VGVPG
#3082Methods related to the treatment of neurodegenerative and inflammatory conditions
#3083Mast cell-derived renin
#3084Bioimplant formulation comprising lecithin and stearin
#3085Antitumorigenic Drug Combination
#3086Control of radiation injury
#3087Method for inhibiting apoptosis through the p75 neurotrophin receptor
#3088SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME X
#3089Somatostatin antagonists
#3090Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity
#3091USE OF TIGHT JUNCTION AGONISTS TO FACILITATE PULMONARY DELIVERY OF THERAPEUTIC AGENTS
#3092Methods and compositions for targeting gC1qR/p32
#3093Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
#3094METHODS TO PREVENT AND TREAT DISEASES
#3095Endometriosis cell targeting peptide and uses thereof
#3096DERMATOLOGICAL USES OF TRI-, TETRA-, PENTA-, AND POLYPEPTIDES
#3097DERMATOLOGICAL USES OF THE TRIPEPTIDE MELANOCYTE STIMULATING INHIBITORY FACTOR (MIF)
#3098Antitumorigenic Drug Combination
#3099Inhibitors of Amyloid Fibril Formation and Uses Thereof
#3100CEACAM based antibacterial agents
#3101Sustained release formulations
#3102Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
#3103Microcystins as agents for treatment of cancer
#3104Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
#3105Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner
#3106Pharmaceutical compositions including low dosages of desmopressin
#3107Pharmaceutical compositions and methods for peptide treatment
#3108Modulation of activity of neurotrophins
#3109Methods and compositions for treating conditions
#3110CLK-peptide and SLK-peptide
#3111Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
#3112Method of modulating the proliferation of medullary thyroid carcinoma cells
#3113Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1
#3114Methods for modulating activities in plants
#3115Dual function polymer micelles
#3116Transdermal delivery of pharmaceutical agents
#3117Methods for promoting, inhibiting and detecting toxin entry into cells
#3118Methods of treating age-related macular degeneration by compstatin and analogs thereof
#3119Anti-aging composition, kit and method of use
#3120Treatment of Cognitive Dysfunction in Lupus
#3121Methods of treating muscular wasting diseases using NF-κB activation inhibitors
#3122C-REACTIVE PROTEIN APHERESIS
#3123Methods of treatment using specific binding agents of human angiopoietin-2
#3124Immune-modulating peptide
#3125Methods and compositions for treating inflammatory disorders
#3126Compounds that inhibit caspase activity for treating glaucoma
#3127Compositions and methods for inhibiting cellular proliferation
#3128Compositions and methods for promoting hemostasis and other physiological activities
#3129Compounds and compositions for prevention of overdose of oxycodone
#3130Peptidyl diacylglycerides
#3131Formulations for a tight junction effector
#3132ORAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS
#3133Pharmaceutical composition
#3134Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
#3135Compound containing a labile disulfide bond
#3136P-selectin targeting ligand and compositions thereof
#3137Compositions and methods for treating diseases
#3138ENHANCED MUCOSAL ADMINISTRATION OF NEUROPROTECTIVE PEPTIDES
#3139Method of treating condition in animal
#3140Methods of cholesterol reduction using isoflavones
#3141MODULATION OF RHAMM-CAVEOLIN/LIPID RAFT INTERACTIONS TO AFFECT DEVELOPMENT, RESPONSES TO TISSUE INJURY, ANGIOGENESIS, TUMORIGENESIS, METASTASIS AND GROWTH FACTOR/CYTOKINE RESPONSES
#3142Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
#3143Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
#3144Hydrogels for modulating cell migration and matrix deposition
#3145Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#3146Drug therapy for Celiac Sprue
#3147Methionine aminopeptidase-2 inhibitors and methods of use thereof
#3148Casein derived peptides and uses thereof in therapy
#3149SELECTIVE TARGETING AGENTS FOR MITCOCHONDRIA
#3150Methods and compositions for diagnosis and treatment of influenza
#3151Peptide conjugated anti-cancer prodrugs
#3152Tumor activated prodrugs
#3153Beta-polypeptides that inhibit cytomegalovirus infection
#3154Uses of myostatin antagonists
#3155Stable solid forms of enterostatin
#3156Peptides that home to tumor lymphatic vasculature and methods of using same
#3157Methods of treating obesity using enterostatin
#3158Non-hygroscopic compositions of enterostatin
#3159Decoy-containing pharmaceutical compositions and method of using the same
#3160Neuroprotective activity of activated protein c independent of its anticoagulant activity
#3161Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
#3162Methods for reducing CD36 expression
#3163Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
#3164Method of treating recurrent miscarriages
#3165Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
#3166Organic compounds
#3167Inhibitor of interaction of granzyme b with golgin-160
#3168Compositions and methods for promoting wound healing and tissue repair
#3169Inhibitors of serine proteases
#3170Hydrogel compositions
#3171HLA class I A2 tumor associated antigen peptides and vaccine compositions
#3172Methods and Compositions for Inhibiting C-MET Dimerization and Activation
#3173Drug comprising synthetic peptide analogs for the treatment of cancer
#3174Methods of treatment using specific binding agents of human angiopoietin-2
#3175Methods of treatment using specific binding agents of human angiopoietin-2
#3176Compositions for administering RNAIII-inhibiting peptides
#3177Detoxification depot for Alzheimer's disease
#3178Peptides, derivatives and analogs thereof, and methods of using same
#3179Angiogenic peptides and uses thereof
#3180Ocular administration of immunosuppressive agents
#3181Anti-chrondrosarcoma compounds
#3182Methods of treatment using specific binding agents of human angiopoietin-2
#3183Antitumor agents
#3184In vivo imaging using peptide derivatives
#3185Use of RIP in treating infections
#3186Composition comprising a nucleotide sequence encoding an ELA2 fusion protein and plasmacytoid dendritic cells
#3187Method for reducing risk of and extent of injury due to stroke in hypertensive subjects
#3188Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
#3189Syndecan 1 ectodomain inhibits cancer
#3190Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
#3191Compositions and methods for modulating connexin hemichannels
#3192Peptide dependent upregulation of telomerase expression
#3193Sequences facilitating penetration of a substance of interest
#3194Somatostatin analogs with inhibitory activity to growth hormone release
#3195Compositions and methods for topical application and transdermal delivery of an oligopeptide
#3196Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of
#3197Medicinal uses of mu-opioid receptor agonists
#3198Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor
#3199Treatment of tumors using short peptides from human chorionic gonadotropin (HCG)
#3200Methods for reducing oxidative damage
#3201Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
#3202INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES
#3203Methionine aminopeptidase-2 inhibitors and methods of use thereof
#3204Pharmaceutical formulations and methods of treatment using the same
#3205Inhibitors of signal transduction and activator of transcription 3
#3206Biomarkers of resistance to infections in humans and biological applications thereof
#3207Direct drug delivery system based on thermally responsive biopolymers
#3208Methods and compositions for the treatment and prevention of and other bacterial infections
#3209Treatment of skin, and wound repair, with thymosin beta 4
#3210Method of treating interferon non-responders using HCV protease inhibitor
#3211Insulin and IGF-1 receptor agonists and antagonists
#3212Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment
#3213ψεRACK peptide composition and method for protection against tissue damage due to ischemia
#3214Method for enhancing bone formation
#3215Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
#3216Pain-sensitive therapeutic wound dressings
#3217Compositions and methods for treatment of eye disorders
#3218Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
#3219Administration of HCV protease inhibitors in combination with food to improve bioavailability
#3220Methods and compositions for the treatment of gastrointestinal disorders
#3221Compositions and methods for the treatment of muscular dystrophy
#3222Methods of treating hepatitis C virus
#3223TOPICAL OLIGOPEPTIDE DELIVERY SYSTEM
#3224Pharmaceutical composition containing decoy and use of the same
#3225Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
#3226Antitumorigenic drug combination and dosing schedule
#3227Compounds for inhibiting cathepsin activity
#3228Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
#3229Methods and compositions for encapsulation of cells
#3230Bio-synthetic matrix and uses thereof
#3231Stable rgd peptidomimetic composition
#3232Preventing and/or remedy hematopoietic tumor
#3233Peptides directed for diagnosis and treatment of amyloid-associated disease
#3234Ophthalmic therapeutic composition
#3235Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements
#3236Peptides impairing PBX dependent gene regulation
#3237Methods for improving the structure and function of arterioles
#3238Method of stimulating growth and resistance to diseases of aquatic organisms
#3239Compositions and methods for treatment of cancer
#3240Method of treatment or prophylaxis
#3241Method for the treatment of prostate cancer
#3242Methods for regulating inflammatory mediators and peptides useful therein
#3243Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies
#3244Colorectal cancer therapies
#3245Stereoselective antifibrillogenic peptides and peptidomimetics thereof
#3246Mixture for transdermal delivery of low and high molecular weight compounds
#3247Methods of treating dry eye disorders
#3248Peptides for diagnostic and therapeutic methods for celiac sprue
#3249Use of effectors of glutaminyl and glutamate cyclases
#3250Mixture for transdermal delivery of low and high molecular weight compounds
#3251Use of a polypeptide for treatment of pruritus in animals
#3252Compositions for preventing and treating digestive organs diseases
#3253Restoring vascular function
#3254Peptide inhibitors against seprase
#3255N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response
#3256Method and composition for inhibiting cardiovascular cell proliferation
#3257Novel conjugates of polysaccharides and uses thereof
#3258Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
#3259Peptides that selectively home to heart vasculature and related conjugates and methods
#3260Method and composition for inhibiting cardiovascular cell proliferation
#3261Growth factor encapsulation system for enhancing bone formation
#3262Methods and compositions for modulating conditions in both mammals and plants
#3263Pharmaceutical formulation
#3264BCR-ABL imatinib resistance-associated peptides and methods of use thereof
#3265Cupredoxin derived transport agents and methods of use thereof
#3266Therapeutic peptide-based constructs
#3267Methods of increasing cerebral blood flow
#3268Detection and treatment of intravascular lesions
#3269Compositions and methods comprising protein activated receptor antagonists
#3270Synthetic peptide, inhibitor to DNA viruses
#3271Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer
#3272Therapeutic formulations for the treatment of beta-amyloid related diseases
#3273Bio-synthetic matrix and uses thereof
#3274Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
#3275AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
#3276Human tissue antigen-binding peptides and their amino acid sequences
#3277Antimicrobial peptides and use thereof
#3278Method of reducing the effects of Abeta and compositions therefore
#3279Dalfopristine/quinupristine combinations with cefpirome
#3280Sustained release ionic conjugate
#3281Methods for preventing and treating Alzheimer's disease
#3282Antimicrobials against pathogenic bacteria and method for screening them
#3283Ligands to radiation-induced molecules
#3284Method for the therapeutic management of endometriosis
#3285Compositions and methods of use of targeting peptides against placenta and adipose tissues
#3286Treatment of infections and other disorders
#3287Topical skin care composition
#3288Apoptotic compounds
#3289Methods for reducing oxidative damage
#3290Sustained-release preparations
#3291Peptide for regulation of urokinase plasminogen activator and method of optimizing therapeutic efficacy
#3292Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
#3293Paclitaxel hybrid derivatives
#3294Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring
#3295Biologically active compounds for the modification of bodily odours
#3296Neuroprotective dietary supplement
#3297Methods of treating dry eye disease with lantibiotics
#3298Organ preconditioning, arrest, protection, preservation and recovery
#3299Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents
#3300Methods for producing target cell reactive lymphocytes